CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenues	$ 0	$ 5,894	$ 65,297	$ 47,359
Operating expenses:
Research and development	5,220	15,104	12,617	49,880
General and administrative	4,609	7,181	19,158	23,163
Total operating expenses	9,829	22,285	31,775	73,043
(Loss) income from operations	(9,829)	(16,391)	33,522	(25,684)
Other income (expense):
Change in fair value of warrant liability	0	0	0	1,603
Interest and dividend income	706	957	2,669	2,282
Other expense, net	(4)	(4)	(7)	(10)
Total other income, net	702	953	2,662	3,875
Net (loss) income	$ (9,127)	$ (15,438)	$ 36,184	$ (21,809)
Net (loss) income per share - basic and diluted:
Basic	$ (1.37)	$ (2.32)	$ 5.43	$ (3.27)
Diluted	$ (1.37)	$ (2.32)	$ 5.43	$ (3.27)
Weighted-average shares used in computing net (loss) income per share - basic and diluted:
Basic	6,663	6,663	6,663	6,663
Diluted	6,663	6,663	6,663	6,663
Revenue from customers
Revenues	$ 0	$ 5,894	$ 752	$ 47,359
Revenue from collaboration agreements
Revenues	$ 0	$ 0	$ 64,545	$ 0